Tag | Content |
---|
EnhancerAtlas ID | HS182-17643 |
Organism | Homo sapiens |
Tissue/cell | Spleen |
Coordinate | chr5:76015250-76017350 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
BHLHE41 | MA0636.1 | chr5:76016210-76016220 | GTCACGTGAC | + | 6.02 | BHLHE41 | MA0636.1 | chr5:76016210-76016220 | GTCACGTGAC | - | 6.02 | MITF | MA0620.2 | chr5:76016206-76016224 | CATGGTCACGTGACTACA | + | 7 | MITF | MA0620.2 | chr5:76016206-76016224 | CATGGTCACGTGACTACA | - | 7 | USF1 | MA0093.2 | chr5:76016209-76016220 | GGTCACGTGAC | - | 6.14 | USF2 | MA0526.2 | chr5:76016208-76016224 | TGGTCACGTGACTACA | - | 6.16 | USF2 | MA0526.2 | chr5:76016206-76016222 | CATGGTCACGTGACTA | + | 6.52 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_14016 | chr5:76015980-76018515 | CD34_Primary_RO01536 | SE_38085 | chr5:76010612-76018283 | HUVEC | SE_45479 | chr5:76015507-76016053 | NHLF |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 2 | ID | Chromosome | Start | End |
GH05I076719 | chr5 | 76015508 | 76016053 | GH05I076721 | chr5 | 76017026 | 76017310 |
|
Enhancer Sequence | CTAAAAATAC AAAATTAGCT GGGTATGGTG GTGCACACCT GTAGTCACAG CTACTTGGGA 60 GGCTGAGGCA CCAGAATTGC CTGAACCTGG AAGGCAGAGG TTGCAGGGAA CTGAGATTGT 120 GCCACTGCAC TCCAGTCTGA GCAACAGAGT GAGACTCTCT CTCAAAAAAA AAAAGAGGTG 180 GAATTGGGAG TTGACCACAG GCCTGTCTCT CCGAAGTGCA GGCTTTCTCT AACACCCCCT 240 ATAGAAAGGA AGCCATCTAG ACTCCCAGCA CCTCTTACAG TAGAGAAGTA ACCCCACTGT 300 GCTCCCTAGT ACAGTATGGA TTTACCTATT TTTGATAATT CATCAAAATA TAGAAGCAAA 360 GTCTGTGCCC TATCGCCTTG GTAGCTCAGG CCCAGCACAG GGAGGTATTT AGTGAGCATT 420 TATGCACGGA CTGTGGTATT CTCTCATTTA CTTTCGCTAA CAGATGATAA GGCAGGCTCT 480 GAAAAGATCC CTGCTCATGA ATACACTAAT TAATCAGATG TTACAAGAGA TATTGCTAGT 540 AAACCTAAAC AGAAAGACAG AAAACTGAGC AGTGGTTCTA CCGTAAGCAG ACCAGAAAGC 600 TCTATAAAGC CTGAAAGTCA GATTTCTTAT GAGTCAGCAA GTAATTTTCT GCCCTACTAT 660 CTATCTATCT ATCTATATCT AATAATTTTT AGTGGCTTTG CCTTTATTTT TATAGAACAT 720 ACCAGCATAG CAGGTTCTCA GGGTCTGGGT GCAGTGGCTC ACACCTGTAA TCCCAGCACT 780 TTGGGAACCC TAGGCCAGAT GATCGCTTGA GACCAGCCTA GGCAACATAG TAAGACCCCA 840 TCTCTATTAA AAAAAATAAT TAAAAAGTAG CCAGGCACTG TGGTGTGCAC CTGTAGTCCC 900 AGCACTTGGG AGACTGGGAG GATGGCCTGA CCCAGGAGTT CAAGGTGGCA GTGAGCCATG 960 GTCACGTGAC TACACTCCAG CCTGGGCAAC AGAGTGGGAG AGACGCTGTC TTCAAAATAT 1020 TTAATAAATG AAAATTTTAA ATTTAAATTA ATCATTTAAA TTTAAAAAAT AAAATAATAA 1080 AATTGAGGTA GAATTCACAT AACATAAAAT TAACCATTTT AAAGTATACA ATTCATTGGT 1140 ATTTAGTACA TTTACAGTGT ACAATGTACA CTGTAAACCC CTACCTACTT CCAAAATCCT 1200 GTCATTTCCC CGAAAGGAAA CCAGTAAGCA GTCAGATCCC ATTCTCCCTT CCCCTACCCC 1260 CAGGAACCAC CAGTTTGCCT TTTTTCTCTA TGGATTTACC TATTTTTGAT ATTTCATATC 1320 AATAGAATCA TATAATATGT GGTCTTAGTG TCTGGGGAAC TTAACTTTAG GTGGGTTAAA 1380 GTTGTTGTTG CTGTTTTTTT GAGACAGGGT CTAGGTGTCT TACTCAGGCT GGAGTGCAGA 1440 GGCACAAATT TGGCTCACTG CAACCTCTGC CTCCCAGGCT CAAGCTATCC TCCTAACTCA 1500 GCCTCCAGAG TAGCTGGGCT ACAGGCACCT GCCACCACGC CTGGCTAATT TTTGTATTTT 1560 TAGTAGAGAC GAGATTTTAT CACACTGCCC AGGCTGTTCT CAAACTCCTG GGATCAAGCG 1620 ATCCACCTAC CTTGGCCTCC CAAAGTGCTG GAATTCTAGG CGTGAGCCAC CATGCCCAGT 1680 CTTTAACTAG TTTTCGTGAG CACCTAGGCT CCCCTTCCAT TGCGGATACT CACAAAAACA 1740 TCCTTGTTAG AAGAGTTATT AGGACTCAGG GCCTTGGTTT ATTTTTGACT ATGATACTAG 1800 TGTTGAGGAC TCCATAGTTT TACCATTCAT AATTTTCTGT TTGTTTCCTT TTTTGCGATT 1860 TCTTTCATTC TGCCTTTTTC TTTCTCTTGC TTGTGCCTAA AACTGTCGTC ATAAATAGCT 1920 CTGTCTATAT ACTGAGAATT TTTTTCTGGG CATGAGCTTT CACTTCCCCA GATACCGTCT 1980 CCCACACTGA CCTTGTCGTG GTACTTGGAG GAAGCCACTT AAAGGGCCCT GACGGTCCTA 2040 TATACATTAT TTGCTTTCAA AAGTAAGTGG CCTTTTGAAA CAACAGGAGT AATCTGCAAT 2100
|